Sean Gaffney - Feb 23, 2024 Form 4 Insider Report for Addus HomeCare Corp (ADUS)

Signature
/s/ Brian Poff, Attorney-in-Fact for Sean Gaffney
Stock symbol
ADUS
Transactions as of
Feb 23, 2024
Transactions value $
-$140,872
Form type
4
Date filed
2/27/2024, 04:10 PM
Previous filing
May 2, 2023
Next filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADUS Common Stock Award $0 +5.66K +40.45% $0.00 19.6K Feb 23, 2024 Direct F1
transaction ADUS Common Stock Sale -$141K -1.64K -8.34% $85.95 18K Feb 26, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares vest in equal installments on each of February 23, 2025, February 23, 2026, and February 23, 2027, subject to customary provisions for continued service and acceleration on a change in control.
F2 This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $85.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.